Giant cell arteritis in sight - Imaging techniques in the ZGT GET cohort

Completed

• Conditions: Giant cell arteritis; 10047066

• Registration Number: NL-OMON49395
• Lead Sponsor: Ziekenhuisgroep Twente

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

Patients with a suspicion of GCA (based on the suspicion of the treating
rheumatologist or the referring general practitioner)

Exclusion Criteria

- Contra-indications, as used in regular care, for the imaging techniques used
(FDG-PET/CT of MRI/MRA)
- Legally incapable

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The diagnosis after 6 months.<br /><br>This will be used to calculate the sensitivity, specificity and AUC to evaluate<br /><br>the validity of the three imaging techniques. These values can then be compared<br /><br>for the three imaging techniques</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The diagnoses after 6 months follow-up<br /><br>This will be used to calculate the sensitivity, specificity and AUC to<br /><br>evaluate the validity of the temporal artery biopsy. This can then also be<br /><br>compared to these values from the three imaging techniques</p><br>